Generative ai

The State of AI: Models, Moats, and the Consumer Renaissance

The State of AI: Models, Moats, and the Consumer Renaissance

Anish Acharya and Jen Kha delve into the evolving AI landscape, dissecting the model layer with its emerging multiple winners and the strategic choice between frontier and open-weight models. They explore how the application layer captures value through model aggregation and specialization, ultimately ushering in a renaissance for consumer AI with personal agents, coding tools, and new economic models, urging founders to think big.

How to build an AI-Native Health Company — Dan Feng, Maven Clinic

How to build an AI-Native Health Company — Dan Feng, Maven Clinic

Dan Feng outlines Maven Clinic's transformation into an AI-native company, driven by the realization that "building is cheap and arguing is expensive" in the AI era. This shift has reshaped planning to short, iterative sprints, revolutionized software development with AI coding tools, forced adaptive changes in code review processes, and necessitated a nuanced, multi-layered approach to ensuring reliability in generative AI systems.

The Next Medium: Why Real-Time Interactive Video Changes Everything — Ahmed Ahres, Reactor

The Next Medium: Why Real-Time Interactive Video Changes Everything — Ahmed Ahres, Reactor

Ahmed Ahres argues that real-time interaction fundamentally changes the medium, not just its speed, especially in generative AI. He defines "world models" as interactive, effectively infinite, and steerable video, drawing parallels with GPS and camera viewfinders. This paradigm shift unlocks new forms of control, intelligent advertising, programmable worlds for robotics and education, and advanced live avatars. He highlights the critical infrastructure challenges of streaming pixels, managing stateful sessions, and achieving global sub-100ms latency, emphasizing that batch infrastructure is unsuitable for real-time applications. Evaluation of consistency for these models remains an unsolved problem.

Chai Discovery's Bitter Lesson: Drug Design Is Another Scaling Problem

Chai Discovery's Bitter Lesson: Drug Design Is Another Scaling Problem

Chai Discovery is revolutionizing drug discovery by treating biology as an engineering problem, leveraging AI—particularly diffusion models and the "bitter lesson" of scaling—to design molecules rather than merely discover them. Their approach has boosted antibody design hit rates from 0.1% to 16%, aiming for a "Molecular CAD" suite that collapses discovery timelines from months to days. They partner with pharma, building infrastructure and creating a data flywheel to develop higher-quality, more targeted medicines for previously undruggable diseases.

SimulationMaxxing: How Nubank ships agents 20× faster with simulations — Shreya Rajpal, Snowglobe

SimulationMaxxing: How Nubank ships agents 20× faster with simulations — Shreya Rajpal, Snowglobe

Nubank, serving 135 million customers, uses AI agents for support. The talk reveals how simulated data for evaluations (evals) has enabled them to ship AI agents 20x faster. By addressing the bottleneck of multi-turn, stateful eval data, Snowglobe's grounded simulations create realistic customer interactions, allowing rapid testing, derisking, and significant improvements in customer satisfaction and self-service rates, even for open-source model experimentation.

How Forward Deployed Engineering is done at Ramp — Leo Mehr

How Forward Deployed Engineering is done at Ramp — Leo Mehr

Leo Mehr, Director of Engineering at Ramp, outlines two critical principles for Forward Deployed Engineering (FDE): "Always Be Scoping" to ensure the delivery of the right product by deeply understanding customer needs and context, and "Scale with Tokens" by strategically integrating AI agents into FDE workflows. He highlights Ramp's success in automating request intake and spec generation using AI, emphasizing the need for both human judgment and AI-driven efficiency to thrive in the future.